Tomohiro Kabuta

Tomohiro Kabuta

Auto-generated profile, based on publicly available information

Tomohiro Kabuta

Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo, 187-8502, Japan

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
MMMasahiro Morita
Masahiro Morita
LLLian Wee Ler
Lian Wee Ler
MFMarc R. Fabian
Marc R. Fabian
NSNadeem Siddiqui
Nadeem Siddiqui
MMMichael Mullin
Michael Mullin
NSNahum Sonenberg
Nahum Sonenberg
The binding of the eukaryotic initiation factor 4E (eIF4E) to the mRNA 5′ cap structure is a rate-limiting step in mRNA translation initiation. eIF4E promotes ribosome recruitment to the mRNA. In Drosophila, the eIF4E homologous protein (d4EHP) forms a complex with binding partners to suppress the translation of distinct mRNAs by competing with eIF4E for binding the 5′ cap structure. This repression mechanism is essential for the asymmetric distribution of proteins and normal embryonic development in Drosophila. In contrast, the physiological role of the mammalian 4EHP (m4EHP) was not known. In this study, we have identified the Grb10-interacting GYF protein 2 (GIGYF2) and the zinc finger protein 598 (ZNF598) as components of the m4EHP complex. GIGYF2 directly interacts with m4EHP, and this interaction is required for stabilization of both proteins. Disruption of the m4EHP-GIGYF2 complex leads to increased translation and perinatal lethality in mice. We propose a model by which the m4EHP-GIGYF2 complex represses translation of a subset of mRNAs during embryonic development, as was previously reported for d4EHP.

1 October 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TKTomohiro Kabuta
Tomohiro Kabuta
YSYasuyuki Suzuki
Yasuyuki Suzuki
KWKeiji Wada
Keiji Wada
Mutations in the Cu,Zn-superoxide dismutase (SOD1) gene cause ∼20% of familial cases of amyotrophic lateral sclerosis (fALS). Accumulating evidence indicates that a gain of toxic function of mutant SOD1 proteins is the cause of the disease. It has also been shown that the ubiquitin-proteasome pathway plays a role in the clearance and toxicity of mutant SOD1. In this study, we investigated the degradation pathways of wild-type and mutant SOD1 in neuronal and nonneuronal cells. We provide here the first evidence that wild-type and mutant SOD1 are degraded by macroautophagy as well as by the proteasome. Based on experiments with inhibitors of these degradation pathways, the contribution of macroautophagy to mutant SOD1 clearance is comparable with that of the proteasome pathway. Using assays that measure cell viability and cell death, we observed that under conditions where expression of mutant SOD1 alone does not induce toxicity, macroautophagy inhibition induced mutant SOD1-mediated cell death, indicating that macroautophagy reduces the toxicity of mutant SOD1 proteins. We therefore propose that both macroautophagy and the proteasome are important for the reduction of mutant SOD1-mediated neurotoxicity in fALS. Inhibition of macroautophagy also increased SOD1 levels in detergent-soluble and -insoluble fractions, suggesting that both detergent-soluble and -insoluble SOD1 are degraded by macroautophagy. These findings may provide further insights into the mechanisms of pathogenesis of fALS.

1 August 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TKTomohiro Kabuta
Tomohiro Kabuta
AFAkiko Furuta
Akiko Furuta
SAShunsuke Aoki
Shunsuke Aoki
KFKoh Furuta
Koh Furuta
KWKeiji Wada
Keiji Wada
Parkinson disease (PD) is the most common neurodegenerative movement disorder. An increase in the amount of α-synuclein protein could constitute a cause of PD. α-Synuclein is degraded at least partly by chaperone-mediated autophagy (CMA). The I93M mutation in ubiquitin C-terminal hydrolase L1 (UCH-L1) is associated with familial PD. However, the relationship between α-synuclein and UCH-L1 in the pathogenesis of PD has remained largely unclear. In this study, we found that UCH-L1 physically interacts with LAMP-2A, the lysosomal receptor for CMA, and Hsc70 and Hsp90, which can function as components of the CMA pathway. These interactions were abnormally enhanced by the I93M mutation and were independent of the monoubiquitin binding of UCH-L1. In a cell-free system, UCH-L1 directly interacted with the cytosolic region of LAMP-2A. Expression of I93M UCH-L1 in cells induced the CMA inhibition-associated increase in the amount of α-synuclein. Our findings may provide novel insights into the molecular links betweenα-synuclein and UCH-L1 and suggest that aberrant interaction of mutant UCH-L1 with CMA machinery, at least partly, underlies the pathogenesis of PD associated with I93M UCH-L1.

7 March 2013 in Autophagy
Verified
Journal Article
Open access
YFYuuki Fujiwara
Yuuki Fujiwara
AFAkiko Furuta
Akiko Furuta
HKHisae Kikuchi
Hisae Kikuchi
SAShu Aizawa
Shu Aizawa
YHYusuke Hatanaka
Yusuke Hatanaka
TKTomohiro Kabuta
Tomohiro Kabuta
Regulated degradation of cellular components by lysosomes is essential to maintain biological homeostasis. In mammals, three forms of autophagy, macroautophagy, microautophagy and chaperone-mediate...

16 January 2015 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
KMKaren E. Murphy
Karen E. Murphy
AGAmanda M. Gysbers
Amanda M. Gysbers
SASarah K. Abbott
Sarah K. Abbott
ASAdena S. Spiro
Adena S. Spiro
AFAkiko Furuta
Akiko Furuta
GHGlenda M. Halliday
Glenda M. Halliday

14 August 2013 in Autophagy
Verified
Journal Article
Open access
YFYuuki Fujiwara
Yuuki Fujiwara
HKHisae Kikuchi
Hisae Kikuchi
SAShu Aizawa
Shu Aizawa
AFAkiko Furuta
Akiko Furuta
YHYusuke Hatanaka
Yusuke Hatanaka
TKTomohiro Kabuta
Tomohiro Kabuta
Lysosomes contain various hydrolases that can degrade proteins, lipids, nucleic acids and carbohydrates. We recently discovered “RNautophagy,” an autophagic pathway in which RNA is directly taken u...